New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 24, 2014
08:36 EDTIBIOiBio receives patent allowance in China for lichenase fusion protein technology
iBio reported the allowance of a Chinese patent on its lichenase fusion protein technology for therapeutic proteins and vaccines.
News For IBIO From The Last 14 Days
Check below for free stories on IBIO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2014
14:17 EDTIBIOLiolios Group to hold a conference
Subscribe for More Information
August 28, 2014
08:37 EDTIBIOiBio receives European patent allowances for protein expression technology
Subscribe for More Information
August 26, 2014
08:34 EDTIBIOiBio enters into $10M stock repurchase agreement with Aspire Capital
iBio announced it has entered into a common stock purchase agreement with Aspire Capital Fund. Within two business days of approval of the transaction by the NYSE MKT, Aspire Capital will complete an initial purchase of 1.14M shares of common stock at 44c per share, the closing sale price of iBio's common stock on the NYSE MKT on the business day prior to entry into the purchase agreement with Aspire Capital, for proceeds of $500,000. After the SEC declares a registration statement effective relating to the transaction, Aspire Capital has committed to purchase up to $9.5M in additional shares of common stock over a 24 month period. No warrants are associated with this agreement.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use